USPTO serial 79035679
BIONORICA GROWING SOLUTIONS FOR YOUR HEALTH
Reviewed by CopyMark Law Group
Reg. 3440920Status 404
- Filing date
- Status date
- Registration date
- Jun 3, 2008
- Examiner
- PEREZ, STEVEN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIONORICA GROWING SOLUTIONS FOR YOUR HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Essential oils; plant extracts for use as cosmetics, hair lotions and perfumery; cosmetics | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary and sanitary preparations for use in the treatment of infection of respiratory tract, infection of urinary tract, urinary obstruction, chronical venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of the liver; pharmaceutical preparations for use in the treatment of angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting and allergy; pharmaceutical preparations, namely, plant extracts for use as an antidepressant, diuretic, hypnotic, sedative, stimulant and tranquilizer; hemorrhoidal ointment, laxatives, nasal decongestant capsules, nasal spray preparation, non-narcotic analgesic, throat lozenges; medicaments for the treatment of gynecological disorders; medicinal preparations in tablet form, namely, tablets for regulating menstruation circulation; drugs for treatment of circulatory organ ailments; hormone preparations for medical use; medicinal preparations for the treatment of ailments of the urinary, genital and anal organs; medicinal preparations for the treatment of blood diseases and disorders; oriental medicine for the treatment of gynecologic disorders; pills for treating dizziness; immune regulators, namely, medicinal preparations for the strengthening of the immune system; pharmaceutical preparations and medicines for the treatment of women's diseases, namely, migraine and depression; medicines for the treatment of breast pain; pharmaceutical preparations and medicines for the treatment of gynecological disorders affecting menstruation, sterility, menstruous syndromes, mammae, mastopathy, mastodynia, climacteric complaints, premenstrual syndrome, dysmenorrhea; dietetic substances adapted for medical use, namely, food for medically restricted diets, food for diabetics, vitamin and mineral supplements, herb teas for medicinal purposes and medicinal teas; medical plasters, bandages and gauze for dressings, wound dressings, all purpose disinfectants; plant extracts, tinctures and aromatic substances in liquid, solid or gaseous form, namely, medicinal herb extracts; nutritional additives for medical purposes for use in foods and dietary supplements for human and animal consumption; dietetic supplements in the form of tablets, drops, capsules, extract preparations, balms and/or in liquid form, containing plant extracts for the treatment of infection of respiratory tract, infection of urinary tract, urinary obstruction, chronical venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of the liver, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting and allergy, women's diseases, namely, migraine and depression, breast pain, gynecological disorders affecting menstruation, sterility, menstruous syndromes, mammae, mastopathy, mastodynia, climacteric complaints, premenstrual syndrome, dysmenorrhea; dietetic supplements in the form of tablets, drops, capsules, extract preparations, balms and/or in liquid form, containing plant extracts for use as an antidepressant, diuretic, hypnotic, sedative, stimulant and tranquilizer, hemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparation, non-narcotic analgesic, throat lozenges; dietetic supplements in the form of tablets, drops, capsules, extract preparations, balms and/or in liquid form, containing plant extracts for the treatment of gynecological disorders; dietetic food supplements; mineral food supplements, food supplements based on amino acids, minerals and trace elements | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bionorica AG
- Other trademarks owned by Bionorica AG
- Other trademarks owned by Bionorica SE
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named BIONORICA GROWING SOLUTIONS FOR YOUR HEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2017 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Aug 25, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 16, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 23, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 23, 2015 | INPC | INVALIDATION PROCESSED | — |
| Sep 9, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 9, 2015 | C71T | CANCELLED SECTION 71 | — |
| Jun 12, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 30, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 27, 2010 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 22, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 22, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 3, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 3, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 18, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 11, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 8, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 18, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 18, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2008 | PAPER RECEIVED | — | |
| Oct 23, 2007 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 22, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 31, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 31, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jul 12, 2007 | PAPER RECEIVED | — | |
| May 10, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 24, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 24, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 24, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 23, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 12, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |